Boston ScientificMEX:BSX -1.65%85 Interest Coverage is 11.91 as of Mar. 2026, which is 93% above its 10-year median of 6.18. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,852.47 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 467 Medical Devices & Instruments companies, Boston Scientific ranks worse than 55.25% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Boston Scientific's
Operating Income
for the
three
months ended in Mar. 2026 was MXN19,331 Mil. Boston Scientific's Interest Expense for the
three
months ended in Mar. 2026 was MXN-1,623 Mil.
Boston Scientific's interest coverage for the quarter that ended in Mar. 2026 was 11.91.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Boston Scientific's Interest Coverage or its related term are showing as below:
MEX:BSX'
s Interest Coverage Range Over the Past 10 Years
Min: 1.89 Med: 6.18 Max: 11.5
Current: 11.5
MEX:BSX's Interest Coverage is ranked worse than 55.25% of 467
companies
in the Medical Devices & Instruments industry
Industry Median: 15.72
vs MEX:BSX: 11.50
Boston Scientific (MEX:BSX) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Boston Scientific Interest Coverage Related Terms
Boston Scientific Interest Coverage Historical Data
* Premium members only.
The historical data trend for Boston Scientific's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MEX:BSX vs EW, GEHC, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Boston Scientific's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) has a Interest Coverage of 11.91 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Boston Scientific and its competitors. This is 93% above median its historical median of 6.18. Over the past decade, Boston Scientific's Interest Coverage has ranged from 1.89 to 11.50. According to the industry distribution chart, Boston Scientific ranks #258 out of 467 companies in the Medical Devices & Instruments industry, placing it in the top 55.2%.
Is Boston Scientific's Interest Coverage too high?
Boston Scientific's current Interest Coverage of 11.91 is 93% above median its 10-year median of 6.18. Over the past 10 years, this metric has ranged from a low of 1.89 to a high of 11.50. The Medical Devices & Instruments industry median Interest Coverage is 15.72. Boston Scientific's value of 11.91 is 24.2% below this industry median. Based on the distribution chart, Boston Scientific ranks #258 out of 467 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Interest Coverage compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #258 out of 467 companies for Interest Coverage. This places Boston Scientific in the lower half of its industry. The industry median Interest Coverage is 15.72. Boston Scientific's value of 11.91 is 24.2% below this benchmark. Historically, Boston Scientific's own Interest Coverage has ranged from 1.89 to 11.50 over the past decade. While the company's 10-year median is 6.18 vs. the industry median of 15.72, Boston Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.72, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Boston Scientific's current Interest Coverage of 11.91 is 24.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Boston Scientific and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boston Scientific's current Interest Coverage is 11.91, which is 93% above median its own 10-year median of 6.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,852.47, compared to a current price of MXN777.00 — trading 58.1% below its estimated fair value. The current Interest Coverage is 11.91, which is 93% above median its 10-year median of 6.18 and 24.2% below the Medical Devices & Instruments industry median of 15.72. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Interest Coverage is 11.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (MEX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of MXN777.00 is trading 58.1% below its estimated GF Value™ of MXN1,852.47.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for MEX:BSX:
Interest Coverage: 11.91 (93% above median its 10-year median of 6.18)
GF Value™: MXN1,852.47 vs. price of MXN777.00 (58.1% below fair value)
Industry Position: 24.2% below the Medical Devices & Instruments median (#258 of 467)
No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score
Get the complete analysis for MEX:BSX
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BSX has been successfully added to your 
